Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D5A6JN
|
|||
| Drug Name |
TVI-Brain-1
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Glioblastoma [ICD-11: 2A00] | Phase 2/3 | [1] | |
| Company |
TVAX Biomedical Olathe, KS
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05685004) Randomized Phase 2b Study of Safety And Efficacy Of TVI-Brain-1 Combined With Conformal Radiotherapy And Temozolomide Vs Standard Therapy In Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.